JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teixeira, M. T.
Right arrow Articles by Dujon, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teixeira, M. T.
Right arrow Articles by Dujon, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 45, 32439-32444, November 5, 1999


Self-catalyzed Cleavage of the Yeast Nucleoporin Nup145p Precursor*

Maria Teresa TeixeiraDagger , Emmanuelle Fabre, and Bernard Dujon§

From the Unité de Génétique Moléculaire des levures (URA 1300 CNRS and UPR 927 Université P. M. Curie), Institut Pasteur, Département des Biotechnologies, 25 Rue du Docteur Roux, 75724 Paris Cedex 15, France

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Nup145p is a component of the nuclear pore complex of Saccharomyces cerevisiae and is essential for mRNA export. Nup145p and its apparent vertebrate homologue are the only known nucleoporins to be composed of two functionally independent peptide moieties resulting from the post-translational cleavage of a large precursor molecule. In this study, the proteolytic cleavage site of Nup145p has been mapped upstream of an evolutionary conserved serine residue. Cleavage occurs at the same site when a precursor is artificially expressed in Escherichia coli. A hydroxyl-containing residue is critical for the reaction, although a thiol-containing residue offers an acceptable replacement. In vitro kinetics experiments using a purified precursor molecule demonstrate that the cleavage is self-catalyzed and that the catalytic domain lies within the N-terminal moiety. Taken altogether, our data are consistent with a proteolytic mechanism involving an N>O acyl rearrangement and a subsequent ester intermediate uncovered in other self-processing proteins.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Nuclear pore complexes (NPCs)1 are large structures through which nucleocytoplasmic exchange of soluble macromolecules occurs in eukaryotic cells. The NPCs of yeast and higher eukaryotes share the same basic architecture, including a characteristic 8-fold symmetry, and are believed to be functionally similar (1-3). Constitutive and regulated import or export through NPCs is generally energy-dependent and requires substrate-specific transporters that are targetted to the NPC via repeat-containing nucleoporins (or nuclear pore proteins) (4-6). In yeast, about 30 nucleoporins have already been identified (7). Yet their precise role in transport reactions and/or in NPC biogenesis is far from being understood.

One of the components of the NPC of Saccharomyces cerevisiae, Nup145p, is expressed as a 145-kDa precursor that is rapidly processed to yield two moieties, a N-terminal domain of 65 kDa (N-Nup145p) and a C-terminal domain of 80 kDa (C-Nup145p) (8, 9). Repression of NUP145 (YGL092w) leads to the rapid accumulation of mRNA molecules in the nucleus, concomitant with a nucleolar disorganization and a clustering of NPCs (10-12).

Previous experiments in which the N- and C-Nup145p domains were expressed separately or as a part of a noncleavable precursor have shown that the two moieties perform distinct functions in the cell (9). C-Nup145p is a component of a NPC subcomplex that includes Nup120p, Nup85p, Nup84p, Seh1p, and Sec13p (9, 13). Mutations in most of these nucleoporins, including C-Nup145p, severely affect mRNA export and nuclear architecture (8, 9, 12, 13). The mature N-Nup145p domain does not belong to this complex. Nevertheless, deletion of the corresponding part of the NUP145 gene is lethal in a genetic context where other nucleoporins, such as Nup188p and Nic96p, are mutated (9). Whereas the function of C-Nup145p is not disturbed in mutants of Nup145p where processing is abolished, the function of N-Nup145p is affected as judged from its interaction with Nup188p. In addition, mislocalization of N-Nup145p in the nucleoplasm occurs when it is expressed separately from C-Nup145p (9). Thus, the existence of a precursor molecule, followed by its processing, are a requisite for the function of N-Nup145p for reasons that remain to be elucidated.

Interestingly, the processing of Nup145p is conserved in evolution. It was recently reported that the putative rat homologue of Nup145p is expressed as a Nup98-Nup96 precursor that is also cleaved in vivo to generate two nucleoporins, the previously characterized nucleoporin Nup98 (14-16), which shares similarity with N-Nup145p and a novel nucleoporin, Nup96 (17). Nup98, expressed independently from an alternatively spliced mRNA is also proteolytically processed (17). As in yeast, the correct maturation of the Nup98-Nup96 and Nup98 precursors is essential for the proper localization of the subsequent cleavage products, suggesting that it may be important for NPC assembly (17).

In this paper, we demonstrate the self-catalyzed processing of Nup145p and localize the processing activity in the N-terminal moiety. The data presented suggest a mechanism involving an ester intermediate as has been described for other self-processing proteins.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA Constructs-- The Escherichia coli expression vector pE151 was constructed by inserting a NdeI/BamHI-digested polymerase chain reaction product, obtained using oligonucleotides A and B (Table I) on a GST-NUP145 fusion gene (10), into pET16b (Novagen). This vector expresses the His396NC891His construct.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Oligonucleotides used in this work

The yeast expression vector pE165 contains the same construct placed under the doxycycline repressible promoter of the plasmid pCM190 (18). This construct was obtained by co-transformation (19) in yeast strain FYBL2-5D (20) of a polymerase chain reaction product (using oligonucleotides C and D on pE151) with the pCM190 linearized DNA (21). Expression was monitored by Western blotting, and the recombinant plasmid was subsequently transformed (22) into the protease-deficient yeast strain BJ2168 (23).

The vectors pE172-175 expressing the His398NC613HA proteins were constructed as was pE151 except that the polymerase chain reaction product was amplified using oligonucleotides E (which introduces the RRASV site) and any of oligonucleotides F, G, H, and I (which introduce the HA tag preceded by the wild type and S606C, S606T, and S606A mutations, respectively). The inserts of these plasmids were completely sequenced (by the MWG-Biotech). For cloning manipulations E. coli strains TG1 (Transgene) or XL2-blue (Stratagene) were used.

Total Protein Extracts and Western Blotting-- Purified tagged proteins or those in total extracts from yeast (9) or E. coli (24) were detected by Western blot using the anti-N-Nup145p polyclonal antibody (10), a monoclonal (HIS-1) anti-polyhistidine-peroxidase conjugate (Sigma), diluted at 1:10,000 and anti-HA-peroxydase conjugate at a dilution 1:500. The peroxidase conjugates were revealed with ECL (Amersham Pharmacia Biotech).

His396NC891His Purifications-- Yeast cells expressing the His396NC891His construct were grown in 1 liter of minimal medium (25) lacking uracil to an A600 of 7.8, washed, frozen at -70 °C, and resuspended in 25 ml of buffer A (150 mM NaCl, 0.1% Triton X-100, 20 mM Tris, pH 8) containing 20 mM imidazole. Cells were broken with a French press at 20,000 p.s.i., and the homogenate was clarified by centrifugation at 27,000 × g for 30 min. Supernatant was injected into a 1-ml HiTrap Chelating column (Amersham Pharmacia Biotech) previously loaded with NiSO4. The column was washed with 5 volumes of buffer A containing 20 mM imidazole and eluted with a linear imidazole gradient from 20 to 300 mM in buffer A. The His386N and C891His cleavage products eluted at the highest concentration of imidazole.

E. coli cells BJ21(DE3)pLysS (Novagen) expressing the His396NC891His construct were induced overnight in 800 ml of LB medium containing 100 µg/ml ampicillin, 34 µg/ml chloramphenicol, and 1 mM isopropyl-1-thio-beta -D-galactopyranoside. Cells were washed, pelleted, resuspended in buffer B (150 mM NaCl, 0.1% Triton X-100, 20 mM Hepes, 8 M urea, pH 8) containing 20 mM imidazole, and sonicated. The homogenate was centrifuged at 40,000 × g for 30 min, and the supernatant was loaded onto a 1-ml HiTrap Chelating column (Amersham Pharmacia Biotech) in an Àkta purifier system (Amersham Pharmacia Biotech). The column was washed with buffer B containing 20 mM imidazole and eluted with a linear gradient of imidazole from 20 to 500 mM in buffer B. The tagged products eluted at 200 mM imidazole. Fractions were pooled, diluted 1:8 in buffer C (20 mM Hepes, 8 M urea, pH 8) containing 20 mM NaCl, injected into a 1-ml HiTrap Q column (Amersham Pharmacia Biotech), and eluted with a linear gradient of NaCl from 20 to 600 mM in buffer C. Two major peaks containing, respectively, the His396N (100 mM NaCl, fraction Ec2; see Fig. 2) and the C891His (350 mM NaCl, fraction Ec1; see Fig. 2) were kept for analysis.

Microsequencing and Mass Spectrometry Determination-- N-terminal sequences of the His396N and C891His fractions purified in yeast and E. coli (see Fig. 2) were determined by Edman degradation. In the Ec1 fraction (see Fig. 2), two minor bands migrating just above the major band corresponding to C891His (with an N terminus Ser-Ile-Trp) were also sequenced and revealed N termini Met-Lys-Asp and Met-Arg-Glu, corresponding to internal sequences of Nup145p at positions 564 and 583, respectively. We suggest that these forms correspond to products of internal initiations of translation that could not be processed. For the mass-spectrometry determination, 150 µg of purified His396N from E. coli (fraction Ec2; see Fig. 2) was dialyzed against 50 mM ammonium bicarbonate and lyophilized. An aliquot of the pellet was dissolved in 100 µl of water/methanol/formic acid (50:50:10) and introduced to a API 365 triple quadrupole mass spectrometer (PE-Sciex, Thornill, Canada).

Precursor Purification-- BL21(DE3)pLysS cells expressing the His398NC613HA(S606C) precursor were grown as above, induced by addition of 1 mM isopropyl-1-thio-beta -D-galactopyranoside and incubated for 45 min at 30 °C. Cells were washed, and the pellet was frozen at -70 °C and resuspended in 10 ml of buffer A containing 20 mM imidazole supplemented with 1 mg of DNase I and 1 mg of RNase A. The homogenate was clarified by centrifugation at 40,000 × g for 15 min and injected to a 1-ml HiTrap Chelating column as above. The column was washed with buffer A containing 20 mM imidazole until the A280 of the eluant reach a minimum and then eluted with a linear gradient of imidazole from 20 to 500 mM in buffer A. A peak at 300-400 mM imidazole contained 500 µg of the mixture His398NC613HA(S606C):His398N in a ratio of approximately 60:40 (see below). To prevent cleavage, it was essential to work rapidly and maintain the temperature during the purification at 4 °C or less.

Radioactive Labeling of Purified Proteins and in Vitro Cleavage Assays-- The His398NC613HA construct containing the RRASV site was used for in vitro labeling (26, 27). Briefly, 10 µg of freshly purified mixture His398NC613HA(S606C):His398N were incubated for 5 min with 6.3 units of the catalytic subunit of the protein kinase (Sigma) in 20 mM Tris, 100 mM NaCl, 12 mM MgCl2, 2.8 mM DTT, and 50 µCi of [gamma -32P]ATP (at >4000 Ci/mmol, ICN) in a total reaction volume of 50 µl. The protein was then separated from the nonincorporated nucleotides by gel filtration on Bio-gel P (Bio-Rad). For time course experiments, 32P-labeled proteins were incubated at a concentration of about 100 nM in 300 mM NaCl, 20 mM Hepes, 0.1% Triton X-100, pH 8, with or without 50 mM DTT. Reactions were then analyzed by SDS-PAGE on a 13% gel, exposed to PhosphorImager cassettes, and analyzed by ImageQuant (Molecular Dynamics). ImageQuant graphs corresponding to the radioactivity along the gel lane were further analyzed by Igor (WaveMetrix, Inc.) using a double gaussian curve fitting procedure (a kind gift from A. Jacquier). The double gaussian curve was then resolved into two single gaussians and integrated.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Analysis of the Cleavage Products of Nup145p-- Previous results suggested that cleavage of Nup145p (Fig. 1) occurs around residues 603-606 (9), but the cleavage site was not located precisely. Therefore, as a first step toward characterization of the processing mechanism, we decided to characterize the cleavage products of Nup145p. To do so, a truncated version of Nup145p (10) containing the expected cleavage region and fused at its N and C termini with several His residues (His396NC891His; Fig. 1) was overexpressed in yeast and purified by affinity chromatography using a Nickel column. A Coomassie Blue staining of the purified products (Fig. 2, lane Sc) shows a major band corresponding in size to the His396N (around 30 kDa) and a minor band corresponding in size to the C891His (around 40 kDa), demonstrating that this truncated construct retains the capacity to be cleaved in vivo. The difficult solubilization of C891His under the native conditions used for this experiment might account for the nonstoichiometry of the two cleavage products. Despite its low abundance, the C891His moiety was gel purified and subjected to Edman degradation. The sequence Ser-Ile-Trp was found at the N terminus of C891His. This sequence corresponds to a unique internal sequence of Nup145p at positions 606-609 (Fig. 1) and thus demonstrates cleavage of the peptide bond immediately upstream of the serine 606. 


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1.   A schematic representation of the wild type Nup145p and its truncated versions. In the wild type, positions of the GLFG repeats, the NRM domain and the RNP-I like motif are depicted (10). The sequence surrounding the cleavage site (arrow) is detailed. First and last amino acid residues of the truncated versions of Nup145p are indicated. The His tag is represented by vertical stripes, and the HA epitope is indicated by dots. All amino acid positions in this paper are relative to the wild type Nup145p (10, 11).


View larger version (76K):
[in this window]
[in a new window]
 
Fig. 2.   Cleavage products of Nup145p in yeast and E. coli. His396NC891His precursor products purified from S. cerevisiae (Sc) and E. coli (Ec) were analyzed by SDS-PAGE (8-16% precast gel, Bio-Rad) followed by Coomassie Blue staining. Ec1 and Ec2 correspond to the two major peaks recovered after the anion exchange chromatography and contain, respectively, the His396N (Ec2) and the C891His (Ec1). The weak band corresponding to mature C891His in yeast is marked with a dot. STD stands for protein standards.

Nup145p Cleavage Occurs in Heterologous System-- Autoproteolysis at internal sites preceding serine, cysteine, or threonine positions is now established for several proteins (28). It was therefore tempting to hypothesize that cleavage of Nup145p could proceed by the same mechanism. To test this possibility, we decided to examine the maturation of Nup145p in a heterologous expression system. The same truncated protein His396NC891His was expressed in E. coli and purified under denaturing conditions on a Nickel column followed by an anion exchange chromatography. Analyzed fractions contained mainly the His396N or the C891His form (Fig. 2, lanes Ec2 and Ec1, respectively), confirming that the cleavage of this precursor also takes place in E. coli. Note that the His396N produced in E. coli has a slightly slower electrophoretic mobility in SDS-PAGE than the His396N produced in yeast. This might be due to post-translational modifications in S. cerevisiae (see "Discussion").

N-terminal microsequencing of the C891His gel purified band (Fig. 2, lane Ec1) revealed an N terminus beginning with the sequence Ser-Ile-Trp, showing that the N terminus of C891His generated by in vivo cleavage is the same in yeast and E. coli. Thus, Nup145p cleavage either requires a trans-acting factor that is present in E. coli or is catalyzed by the Nup145p protein itself.

The results presented above show that cleavage occurs at the peptidyl bond preceding the serine 606 generating a free amino group. To characterize the C-terminal generated by the proteolytic reaction, we analyzed the purified His396N produced in E. coli (Fig. 2, lane Ec2) by mass spectrometry. One peak at 26,428 ± 83 Da was obtained that corresponds to the theoretical mass expected for the His396N lacking the first methionine (26,427.41 Da). N-terminal microsequencing of the gel purified band (Fig. 2, lane Ec2) indeed confirms that His396N starts with the glycine immediately following the methionine.

From these measurements, we conclude that proteolysis occurs between phenylalanine 605 and serine 606 and that the last residue of His396N generated by cleavage is not additionally modified. Cleavage in E. coli is therefore the result of hydrolysis of the 605-606 peptide bond, generating two peptides with free C and N termini.

Role of the Hydroxyl Side Chain of the Serine 606-- Self-proteolysis reactions preceding serines, cysteines, or threonines involve a nucleophilic attack by the hydroxyl or thiol group of the respective amino acids on the preceding peptide bond, resulting in the replacement of the peptide bond by an ester or a thioester bond (28). These bonds are more reactive than the peptide bonds and can then be attacked by a second nucleophile and broken. This model implies that any of the three residues serine, cysteine, or threonine is essential for the reaction and can be replaced by one another with only limited effects on catalytic activity (29, 30).

Because Nup145p cleavage takes place before a serine, we tested the importance of the hydroxyl residue in the reaction. Therefore, serine 606 was replaced by a cysteine, a threonine, or an alanine by directed mutagenesis. For experimental purposes, we used an even shorter truncated version of Nup145p (His398NC613HA; Fig. 1), where the C-Nup145p is almost entirely substituted by the HA tag. Each construct was then transformed into E. coli, and expression of the encoded protein was induced. The processing capacity of the different precursors was analyzed at different times after induction (Fig. 3).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   A hydroxyl- or thiol-containing residue is critical for cleavage. Total protein extracts from E. coli expressing the His398NC613HA constructs harboring either the wild type (WT) or the mutated (S606C, S606T, and S606A) cleavage site were incubated for various time intervals after induction, separated by SDS-PAGE (13% gel) and transferred to nitrocellulose. The tagged proteins were detected using either anti-His (alpha -His) or anti-HA (alpha -HA) antibodies. Note that the minor anti-His reacting band above the mature His398N in WT does not correspond in size to the precursor form.

For the wild type form His398NC613HA(WT), a major band that corresponds in size to the mature N-terminal moiety is revealed by Western blot using the antibody directed against the His tag (Fig. 3, alpha -His). This band is nearly constant in intensity for all time points analyzed after induction. The antibody directed against the HA tag only detects a faint band migrating about 2 kDa above the mature form as expected for the precursor molecule (Fig. 3, alpha -HA). This experiment indicates that the truncated version of Nup145p retains the capacity to undergo cleavage in vivo and that the processing is already efficient even at early stages after induction. Thus, deletion of most C-Nup145p does not affect the cleavage capacity.

On the contrary, expression of the S606A mutation leads to the formation of a single major band throughout the kinetics experiment corresponding in size to the precursor and reacting with both anti-His (Fig. 3, alpha -His) and anti-HA (Fig. 3, alpha -HA) antibodies. Thus, the S606A mutation completely abolishes proteolytic cleavage of the precursor molecule.

Expression of the S606C mutant produced two anti-His reacting forms. They correspond respectively to the precursor form, which also reacts with the anti-HA antibody and with the mature N-terminal form (Fig. 3), showing that proteolytic cleavage can take place in this mutant. The precursor form is the major product at early stages after induction (Fig. 3, alpha -His, 1.5 h and decreases at later stages (Fig. 3, alpha -His, 6 h. This shows that the cleavage reaction is delayed in this mutant compared with the results obtained for the wild type. The situation is similar for the S606T mutant, with the difference that the ratio of precursor to product observed along the time course is slightly lower, suggesting that this mutation is less deleterious to the cleavage reaction in vivo. Overall, these results suggest that a hydroxyl- or thiol-containing residue at the cleavage junction is required for the reaction.

In Vitro Cleavage of a Purified Precursor-- To demonstrate definitively that the cleavage of the Nup145p precursor is a self-catalyzed process, we undertook the purification of a precursor form and tested its ability to undergo self-cleavage in vitro. Precursor purification from the wild type construct would be very difficult because of the high efficiency of the in vivo processing (see above). We therefore made use of the mutants S606C and S606T to define conditions under which the precursor form accumulates. The best yield of uncleaved precursor was obtained using the S606C mutant induced for a short time (45 min) at 30 °C (data not shown). Protein products were then extracted and purified on a nickel column under native conditions. The purification was assessed by SDS-PAGE followed by Coomassie Blue staining (Fig. 4A). Two major bands corresponding respectively to the His398NC613HA(S606C) precursor and to the His398N product were obtained, indicating that partial cleavage of the precursor does occur during extraction but that the proportion of precursor molecules is sufficiently high to allow subsequent analysis in in vitro reactions.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   In vitro cleavage of Nup145p in the mutated version His398NC613HA(S606C). A, E. coli His398NC613HA(S606C):His398N purified mixture resolved by SDS-PAGE (13% gel) and stained with Coomassie Blue. STD stands for protein standards. B, the purified mixture was radiolabeled and diluted in the reaction buffer with (+DTT) or without (-DTT) 50 mM DTT. The samples taken at different times were analyzed by SDS-PAGE (13% gel) and gel scanning. Total amounts of radioactivity are not significantly different between lanes. C, quantification of three independent experiments as in B.

To quantify the cleavage reactions, we chose to follow radiolabeled products. For this purpose, we introduced the artificial pentapeptide phosphorylation site RRASV (26, 27) following the His tag in the His398NC613HA construct. Using [gamma -32P]ATP as substrate, the purified mixture His398NC613HA(S606C):His398N was labeled by phosphorylation using a commercial bovine kinase. Analysis of proteins by SDS-PAGE followed by gel scanning shows that both His398NC613HA(S606C) and His398N were successfully labeled (Fig. 4B, 0 min).

The next step was to determine adequate conditions for the in vitro cleavage. To do so, we hypothesized that the requirement for a hydroxyl (or thiol) group at the cleavage site of Nup145p precursor reflects the involvement of an ester (or a thioester) intermediate in the mechanism. Because thioesters are particularly susceptible to nucleophiles (31), we decided to test for the reactivity of His398NC613HA(S606C) in the presence of DTT known to accelerate this type of reaction (30, 32, 33). The in vitro cleavage was then performed with or without 50 mM DTT at 30 °C, and aliquots of the reaction were analyzed at different times (Fig. 4B). In the presence of DTT, the band corresponding to the precursor decreases concomitantly with the increase of the band corresponding to the mature product. This precursor-product kinetic relationship demonstrates that His398NC613HA(S606C) has the capacity to self-process in vitro into His398N in the presence of DTT. In the absence of DTT, the ratio His398NC613HA(S606C):His398N is maintained during the 2 h of the reaction (Fig. 4B). Because DTT-induced cleavage could involve the thiol as a nucleophile or as a reductant, we made use of a nonthiol disulfide reductant, the tris(2-carboxyethyl)phosphine (34). We found that the half-life of the precursor in the presence of 50 mM tris(2-carboxyethyl)phosphine was increased 15 times compared with the reaction in the presence of 50 mM DTT in a 2 h reaction (see below and data not shown). This suggests that the accelerating effect of DTT on the in vitro cleavage reaction is due to its ability to carry out nucleophilic attack. Longer times of incubation were attempted, but results were obscured by unspecific secondary reactions, which might be due to partial denaturation of the precursor. Consistent with this hypothesis is the observation that reaction is less efficient at higher concentrations of protein, resulting in its precipitation (data not shown).

Quantification of the reaction was done from three independent experiments (Fig. 4C). At time 0 of the experiments, the ratio His398NC613HA(S606C):His398N was ~60:40. In the presence of DTT, this ratio decreased to about 30:70 in 2 h, whereas in the absence of DTT, it remained unchanged. The points obtained for the incubation in the presence of DTT suggest a (pseudo) first order reaction, and the precursor half-life time is comprised between 8.6 and 11.5 min. Under the conditions used, approximately half of the purified precursor was able to cleave into the mature form. The incomplete character of the reaction might be due to partial denaturation of the molecules as mentioned above. However, we cannot exclude the possibility that the independent secondary reactions may become non-negligible at late times of incubation, either because of the purification process or because of other uncharacterized proprieties of the precursor.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Post-translational cleavage of the yeast nucleoporin Nup145p generates two functionally distinct proteins. The different lines of evidence presented here support the notion that this reaction is self-catalyzed. First, Nup145p cleavage is observed in heterologous expression systems including E. coli and a mammalian in vitro transcription/translation system (data not shown). Second, a purified precursor form of Nup145p is cleaved in vitro following a (pseudo) first order reaction kinetics (at least for the early times of the reaction) and cleavage occurs in highly diluted samples, free of detectable contaminants. The participation of a hypothetical specific trans-acting factor, conserved in both prokaryotes and eukaryotes, is therefore highly improbable. Third, all our results are consistent with the mechanism described for autoproteolysis taking place in peptide bonds preceding hydroxyl- or thiol-containing residues; in particular, the in vitro reaction studied here is dependent upon the presence of DTT.

It has been known since the 1960s that peptide bonds involving hydroxyl-containing residues can shift to ester bonds (N>O acyl rearrangement) under laboratory conditions (35). There is now formal evidence that these reactions exist in several protein maturation pathways, including protein splicing (36), hedgehog protein maturation (32), pyruvoyl enzymes (37), and N-terminal nucleophile hydrolases (29, 38) activations. In these cases, the hydroxyl- or thiol-containing residues, serine, threonine, or cysteine, undergo a N>O or a N>S acyl-shift resulting in an ester or thioester bond much more reactive than the peptide bond. The ester or thioester bond is then resolved by an attack by a second nucleophile that can be for example water (N-terminal nucleophile hydrolases) (39) or cholesterol (hedgehog) (40). Our results do not provide direct evidence for the exact reaction mechanism involved but are consistent with previous mechanisms since they include (i) the cleavage site before a serine, (ii) requirement for a hydroxyl or thiol group at the cleavage position, (iii) the sensitivity of in vitro cleavage of the S606C mutant to DTT, and (iv) the incapacity of tris(2-carboxyethyl)phosphine to promote such a cleavage. In addition, cleavage of Nup145p in E. coli results from the hydrolysis of peptide bond 605-606, indicating that water might account for the second nucleophilic attack. We cannot exclude, however, that the proteolysis in yeast may involve other modifications, as suggested by the difference in electrophoretic mobility observed for the His396N produced in yeast and in bacteria. This situation may be reminiscent of hedgehog processing, where the covalent addition of cholesterol during the self-catalyzed processing results in an increased mobility on SDS-PAGE of the mature protein (40, 41).

The catalytic domain for the proteolysis of Nup145p must be included between amino acids 398 and 613 because the minimal protein used in this study, His398NC613HA, is still able to undergo self-processing. Taken together with other independent experiments (8), the catalytic site can be narrowed down to the regions containing amino acids 398-523 and 593-613. Furthermore, deletion of the region comprised between residues 470 and 551 abolishes cleavage (10). This latter region contains a RNP-I-like octapeptide motif (Fig. 1) and was proposed to be responsible for RNA affinity of Nup145p in vitro (10). Preliminary experiments show that point mutations in this octapeptide also affect cleavage (data not shown), suggesting that this region may be part of the catalytic site or necessary for its correct folding.

Nup145p has a putative homologue in vertebrates, Nup98-Nup96, that is also cleaved in vivo at the serine of the conserved cleavage site (17). Sequence similarity between Nup98-Nup96 and Nup145p (9, 17) is particularly extensive in the region that we have determined as necessary for the self-processing of Nup145p. It can thus be proposed that the mechanism of processing of the Nup98-Nup96 precursor is also self-catalyzed. Self-processing systems offer the advantage that the specificity is built up into a single molecule (42) and limit the control of the cell over the reaction unless specific interactions may affect the reaction in vivo. Interestingly, maturation of either yeast Nup145p or rat Nup98-Nup96, has a direct role in the localization of the precursor and the subsequent cleavage products (9, 17). Thus, self-cleavage of these nucleoporin precursors may have been conserved in eukaryotes for the specific targeting to the NPC.

    ACKNOWLEDGEMENTS

We thank J. D'Alayer for protein sequencing and A. Namane and O. Barzu for mass spectrometry determination. We also thank A.-M. Gilles, P. Roux, F. Colland, and A. Jacquier for useful advice during the progression of this work; G. Chanfreau, C. Fairhead, and U. Nehrbass for critical reading of the manuscript; and all members of the laboratory for fruitful discussions. M. T. T. thanks all participants of the Cold Spring Harbor course on protein purification and characterization (1998).

    Note Added in Proof

Another report of self-catalysis of rat Nup98 precursor appeared while this article was in press (Rosenblum, J. S., and Blobel, G. (1999) Proc, Natl. Acad. Sci. U. S. A. 96, 11370-11375).

    FOOTNOTES

* This work was supported in part by DGXII of the European Commission "EUROFAN" Grant BIO4-CT97-2294.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of the Fundação para a Ciência e Tecnologia and PRAXIS XXI Program Grant BD/5226/95). To whom correspondence should be addressed. Tel.: 33-01-40-61-34-54; Fax: 33-01-40-61-34-56; E-mail: teresatf@pasteur.fr.

§ Professor of Molecular Genetics at Université P. M. Curie and a member of the Institut Universitaire de France.

    ABBREVIATIONS

The abbreviations used are: NPC, nuclear pore complex; PAGE, polyacrylamide gel electrophoresis; DTT, dithiothreitol; HA, hemagglutinin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Allen, T. D., Bennion, G. R., Rutherford, S. A., Reipert, S., Ramalho, A., Kiseleva, E., and Goldberg, M. W. (1997) Scanning 19, 403-410[Medline] [Order article via Infotrieve]
2. Yang, Q., Rout, M. P., and Akey, C. W. (1998) Mol. Cell 1, 223-234[CrossRef][Medline] [Order article via Infotrieve]
3. Ohno, M., Fornerod, M., and Mattaj, I. W. (1998) Cell 92, 327-336[CrossRef][Medline] [Order article via Infotrieve]
4. Mattaj, I. W., and Englmeier, L. (1998) Annu. Rev. Biochem. 67, 265-306[CrossRef][Medline] [Order article via Infotrieve]
5. Corbett, A. H., and Silver, P. A. (1997) Microbiol. Mol. Biol. Rev. 61, 193-211[Abstract]
6. Nigg, E. A. (1997) Nature 386, 779-787[CrossRef][Medline] [Order article via Infotrieve]
7. Fabre, E., and Hurt, E. (1997) Annu. Rev. Genet. 31, 277-313[CrossRef][Medline] [Order article via Infotrieve]
8. Emtage, J. L. T., Bucci, M., Watkins, J. L., and Wente, S. R. (1997) J. Cell Sci. 110, 911-925[Abstract]
9. Teixeira, M. T., Siniossoglou, S., Podtelejnikov, S., Benichou, J. C., Mann, M., Dujon, B., Hurt, E., and Fabre, E. (1997) EMBO J. 16, 5086-5097[CrossRef][Medline] [Order article via Infotrieve]
10. Fabre, E., Boelens, W. C., Wimmer, C., Mattaj, I. W., and Hurt, E. C. (1994) Cell 78, 275-289[CrossRef][Medline] [Order article via Infotrieve]
11. Wente, S. R., and Blobel, G. (1994) J. Cell Biol. 125, 955-969[Abstract/Free Full Text]
12. Dockendorff, T. C., Heath, C. V., Goldstein, A. L., Snay, C. A., and Cole, C. N. (1997) Mol. Cell. Biol. 17, 906-920[Abstract]
13. Siniossoglou, S., Wimmer, C., Rieger, M., Doye, V., Tekotte, H., Weise, C., Emig, S., Segref, A., and Hurt, E. C. (1996) Cell 84, 265-275[CrossRef][Medline] [Order article via Infotrieve]
14. Radu, A., Moore, M. S., and Blobel, G. (1995) Cell 81, 215-222[CrossRef][Medline] [Order article via Infotrieve]
15. Powers, M., Macauley, C., Masiarz, F. R., and Forbes, D. J. (1995) J. Cell Biol. 128, 721-736[Abstract/Free Full Text]
16. Powers, M. A., Forbes, D. J., Dahlberg, J. E., and Lund, E. (1997) J. Cell Biol. 136, 241-250[Abstract/Free Full Text]
17. Fontoura, B. M., Blobel, G., and Matunis, M. J. (1999) J. Cell Biol. 144, 1097-1112[Abstract/Free Full Text]
18. Gari, E., Piedrafita, L., Aldea, M., and Herrero, E. (1997) Yeast 13, 837-848[CrossRef][Medline] [Order article via Infotrieve]
19. Meilhoc, E., Masson, J. M., and Teissie, J. (1990) Bio/Technology 8, 223-227[CrossRef][Medline] [Order article via Infotrieve]
20. Fairhead, C., Llorente, B., Denis, F., Soler, M., and Dujon, B. (1996) Yeast 12, 1439-57[CrossRef][Medline] [Order article via Infotrieve]
21. Ma, H., Kunes, S., Schatz, P. J., and Botstein, D. (1987) Gene (Amst.) 58, 201-216[CrossRef][Medline] [Order article via Infotrieve]
22. Chen, D.-C., Yang, B.-C., and Kuo, T.-T. (1992) Curr. Genet. 21, 83-84[CrossRef][Medline] [Order article via Infotrieve]
23. Aris, J. P., and Blobel, G. (1988) J. Cell Biol. 107, 17-31[Abstract/Free Full Text]
24. Marshak, D. R., Kadonaga, J. T., Burguess, R. R., Knuth, M. W., Brennan, W. A. J., and Lin, S.-H. (1996) Strategies For Protein Purification And Characterization: A Laboratory Course Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
25. Sherman, F., Fink, G. R., and Hicks, J. B. N. (1986) Methods in Yeast Genetics: A Laboratory Course Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
26. Arthur, T. M., and Burgess, R. R. (1998) J. Biol. Chem. 273, 31381-31387[Abstract/Free Full Text]
27. Colland, F., Orsini, G., Brody, E. N., Buc, H., and Kolb, A. (1998) Mol. Microbiol. 27, 819-829[CrossRef][Medline] [Order article via Infotrieve]
28. Perler, F. B. (1998) Nat. Struct. Biol. 5, 249-252[CrossRef][Medline] [Order article via Infotrieve]
29. Guan, C., Cui, T., Rao, V., Liao, W., Benner, J., Lin, C. L., and Comb, D. (1996) J. Biol. Chem. 271, 1732-1737[Abstract/Free Full Text]
30. Xu, M. Q., and Perler, F. B. (1996) EMBO J. 15, 5146-5153[Medline] [Order article via Infotrieve]
31. Jencks, W. P., Cordes, S., and Carriulo, J. (1960) J. Biol. Chem. 235, 3608-3614[Free Full Text]
32. Porter, J. A., von Kessler, D. P., Ekker, S. C., Young, K. E., Lee, J. J., Moses, K., and Beachy, P. A. (1995) Nature 374, 363-366[CrossRef][Medline] [Order article via Infotrieve]
33. Chong, S., Williams, K. S., Wotkowicz, C., and Xu, M. Q. (1998) J. Biol. Chem. 273, 10567-10577[Abstract/Free Full Text]
34. Burns, J. A., Butler, J. C., Moran, J., and Whitesides, G. M. (1991) J. Org. Chem. 56, 2648-2650[CrossRef]
35. Iwai, K., and Ando, T. (1967) Methods Enzymol. XI, 263-282
36. Shao, Y., Xu, M. Q., and Paulus, H. (1996) Biochemistry 35, 3810-3815[CrossRef][Medline] [Order article via Infotrieve]
37. van Poelje, P. D., and Snell, E. E. (1990) Annu. Rev. Biochem. 59, 29-59[Medline] [Order article via Infotrieve]
38. Schmidtke, G., Kraft, R., Kostka, S., Henklein, P., Frommel, C., Lowe, J., Huber, R., Kloetzel, P. M., and Schmidt, M. (1996) EMBO J. 15, 6887-6898[Medline] [Order article via Infotrieve]
39. Guan, C., Liu, Y., Shao, Y., Cui, T., Liao, W., Ewel, A., Whitaker, R., and Paulus, H. (1998) J. Biol. Chem. 273, 9695-9702[Abstract/Free Full Text]
40. Porter, J. A., Young, K. E., and Beachy, P. A. (1996) Science 274, 255-259[Abstract/Free Full Text]
41. Porter, J. A., Ekker, S. C., Park, W. J., von Kessler, D. P., Young, K. E., Chen, C. H., Ma, Y., Woods, A. S., Cotter, R. J., Koonin, E. V., and Beachy, P. A. (1996) Cell 86, 21-34[CrossRef][Medline] [Order article via Infotrieve]
42. Little, J. W. (1993) J. Bacteriol. 175, 4943-4950[Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. A. Ratner, A. E. Hodel, and M. A. Powers
Molecular Determinants of Binding between Gly-Leu-Phe-Gly Nucleoporins and the Nuclear Pore Complex
J. Biol. Chem., November 23, 2007; 282(47): 33968 - 33976.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
D. A. Barbash
Nup96-Dependent Hybrid Lethality Occurs in a Subset of Species From the simulans Clade of Drosophila
Genetics, May 1, 2007; 176(1): 543 - 552.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. P. Denning and M. F. Rexach
Rapid Evolution Exposes the Boundaries of Domain Structure and Function in Natively Unfolded FG Nucleoporins
Mol. Cell. Proteomics, February 1, 2007; 6(2): 272 - 282.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
G. Parry, S. Ward, A. Cernac, S. Dharmasiri, and M. Estelle
The Arabidopsis SUPPRESSOR OF AUXIN RESISTANCE Proteins Are Nucleoporins with an Important Role in Hormone Signaling and Development
PLANT CELL, July 1, 2006; 18(7): 1590 - 1603.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Robinson, S. Park, Z.-Y. J. Sun, P. A. Silver, G. Wagner, and J. M. Hogle
Multiple Conformations in the Ligand-binding Site of the Yeast Nuclear Pore-targeting Domain of Nup116p
J. Biol. Chem., October 21, 2005; 280(42): 35723 - 35732.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lutzmann, R. Kunze, K. Stangl, P. Stelter, K. F. Toth, B. Bottcher, and E. Hurt
Reconstitution of Nup157 and Nup145N into the Nup84 Complex
J. Biol. Chem., May 6, 2005; 280(18): 18442 - 18451.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-H. Lin, G.-W. Chang, J. Q. Davies, M. Stacey, J. Harris, and S. Gordon
Autocatalytic Cleavage of the EMR2 Receptor Occurs at a Conserved G Protein-coupled Receptor Proteolytic Site Motif
J. Biol. Chem., July 23, 2004; 279(30): 31823 - 31832.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. W. Bai, J. Rouquette, M. Umeda, W. Faigle, D. Loew, S. Sazer, and V. Doye
The Fission Yeast Nup107-120 Complex Functionally Interacts with the Small GTPase Ran/Spi1 and Is Required for mRNA Export, Nuclear Pore Distribution, and Proper Cell Division
Mol. Cell. Biol., July 15, 2004; 24(14): 6379 - 6392.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
C. P. C. De Souza, K. P. Horn, K. Masker, and S. A. Osmani
The SONBNUP98 Nucleoporin Interacts With the NIMA Kinase in Aspergillus nidulans
Genetics, November 1, 2003; 165(3): 1071 - 1081.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Vasu, S. Shah, A. Orjalo, M. Park, W. H. Fischer, and D. J. Forbes
Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export
J. Cell Biol., October 29, 2001; 155(3): 339 - 354.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teixeira, M. T.
Right arrow Articles by Dujon, B.
Right arrow Search for Related Content